Jeffrey Biss Email

VP, Global Information Technology . MeiraGTx

London/New York,

Location

Current Roles

Employees:
472
Revenue:
$20.4M
About
MeiraGTx, a London and New York-based gene therapy company, is committed to the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. We are pioneering the use of gene therapy to treat devastating neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). We are developing innovative gene therapies for ocular diseases including rare inherited blindness and age-related macular degeneration (AMD). MeiraGTx is also establishing treatments for xerostomia, a frequent and debilitating side effect of radiation treatment used in head and neck cancers. Our revolutionary gene regulation technologies promise to transform the way gene therapy can be applied and create new paradigms for biologic therapeutics.
MeiraGTx Address
430 East 29th Street
London/New York, null
UK
MeiraGTx Email

Past Companies

MeiraGTxVP, Global Information Technology
GenosityExecutive Director, Information Technology
MetLife StadiumSenior Director Information Technology

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.